Distribution of the regulatory peptide alarin in the eye of various species
Highlights
► Alarin in corneal epithelium/conjunctiva might indicate a role in immune defense. ► Alarin in corneal endothelium/ciliary body might indicate a role in fluid dynamics. ► Alarin in intrinsic choroidal neurons might indicate a role in neuromodulation. ► Alarin in blood vessels might indicate a role in ocular blood flow regulation.
Introduction
To achieve proper homeostasis for optimal visual function, the eye is controlled by the autonomic nervous system (Neuhuber and Schrödl, 2011). This autonomic control is achieved via nerve fibers of sympathetic, parasympathetic as well as primary afferent origin, each using specific “modulators” to adequately set ocular blood flow or aqueous humor dynamics. These modulators include classical transmitters like catecholamines or acetylcholine for the sympathetic or parasympathetic pathways, respectively, however, during the last decades many other neuroactive substances have been introduced, such as the gas nitric oxide (Boeckxstaens et al., 1991), purinergic compounds (Burnstock, 2010), or regulatory peptides. Regulatory peptides represent a class of small protein-like molecules involved not only in neurosignalling or co-transmission of the classical neurotransmitters (Troger et al., 2007), but also in inflammatory processes and pain sensation (Raddant and Russo, 2011), immune defense (Souza-Moreira et al., 2011), osmoregulation (Kozniewska and Romaniuk, 2008), and behavior (Nixon et al., 2012) or memory function (Crawley, 2010).
In the eye, however, the interaction of the various neurotransmitters and regulatory peptides in ocular regulation is poorly understood.
Alarin is a recently discovered small peptide of 25 amino acids (Santic et al., 2006) and belongs to the galanin family of peptides (Lang et al., 2007). It was described in human neuroblastic tumor as a splice variant lacking exon3 of the galanin-like peptide (GALP) mRNA (Santic et al., 2006), thereby also missing the galanin-receptor binding domain and thus possibly using different receptors for its action. Splice variants exist for other regulatory peptides, e.g. CGRP (Rosenfeld et al., 1983), or neuropeptide Y (Melas et al., 2012), which leads to a diversification of proteins resulting from a single gene and hence to a reduction of the underlying genetic code (Matlin et al., 2005).
Alarin is detectable in neurons of various CNS regions (Eberhard et al., 2012) as well as in epithelial cells and around blood vessels (Eberhard et al., 2012; Santic et al., 2007), but is also found in neuroblastic tumors (Santic et al., 2006). In animal experiments in mice and rats it shows endocrine functions stimulating appetite and reproductive hormone secretion (Boughton et al., 2010; Fraley et al., 2012; Van Der Kolk et al., 2010). Furthermore, alarin inhibits neurogenic inflammation by vasoconstriction in the murine skin (Santic et al., 2007).
Since the regulation of the vessel diameter is a key player in ocular blood flow, and therefore ocular homeostasis, alarin is of potential interest for experimental ophthalmology. Here, we investigate the existence of alarin in eyes of rat, mouse and human by morphological and molecular biological methods.
Section snippets
Tissue preparation
Eyes of rat (Brown Norway; n = 4), mouse (C57Bl/6; n = 3), and human (n = 5; of both sex; 47–84 years of age; post mortem time 5–12 h). Study with human tissue was performed according to the Austrian Gene Technology Act. Experiments were performed in accordance with the Helsinki declaration of 1975 (revised 1983) and the guidelines of the Salzburg State Ethics Research Committee being no clinical drug trial or epidemiological investigation. Furthermore, the study did not extend to examination
Rat
Alarin-like immunoreactivity (alarin-LI) in rat was detected in epithelial cells of the conjunctiva (Fig. 2a) and cornea (Fig. 2b), in the latter one more pronounced in deeper layers than superficially, and in corneal endothelial cells (Fig. 2c). A nuclear staining was not observed here. In the corneal stroma, alarin-LI was absent. In the iris, immunoreactivity was weaker; however, a clear signal was detectable around stromal blood vessels (Fig. 2d). In the ciliary body, the non-pigmented
Discussion
We provide here the first evidence for alarin expression in human and rodent eyes. Alarin immunoreactivity was detectable in ocular epithelial cells (conjunctiva, cornea, ciliary body), blood vessels (iris, retina, choroid) and neurons (retina, human choroid). Immunohistochemcial data in human retina and choroid were confirmed via quantitative Real-time-PCR.
Disclosure
All authors disclose any actual or potential conflict of interest; all authors have approved the final article.
Acknowledgments
Adele Rabensteiner Foundation, Austrian Academy of Sciences, Lotte Schwarz Endowment for Experimental Ophthalmology and Glaucoma Research, PMU FFF (E-11713/068-SRO), The Fuchs Foundation and Austrian Research Promotion Agency (FFG: Project number: 822782/THERAPEP)
References (38)
- et al.
New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland
Prog. Retin. Eye Res.
(2007) - et al.
Effects of alarin on food intake, body weight and luteinizing hormone secretion in male mice
Neuropeptides
(2012) - et al.
Somatostatin modulates PI3K-Akt, eNOS and NHE activity in the ciliary epithelium
Mol. Cell. Endocrinol.
(2006) - et al.
Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease
Prog. Retin. Eye Res.
(2012) - et al.
The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease
Pharmacol. Ther.
(2007) - et al.
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
Methods
(2001) - et al.
Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways
Exp. Cell. Res.
(1992) - et al.
Regulation of vascular reactivity by established and emerging GPCRs
Trends Pharmacol. Sci.
(2005) Corneal endothelial autocrine trophic factor VIP in a mechanism-based strategy to enhance human donor cornea preservation for transplantation
Exp. Eye Res.
(2012)- et al.
Neuropeptide Y: identification of a novel rat mRNA splice-variant that is downregulated in the hippocampus and the prefrontal cortex of a depression-like model
Peptides
(2012)
Autonomic control of the eye and the iris
Auton. Neurosci.
Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects
Pharmacol. Biochem. Behav.
Strain-dependent hippocampal protein levels of GABA(B)-receptor subunit 2 and NMDA-receptor subunit 1
Neurochem. Int.
Endothelin-1: physiological and pathological roles in myometrium
Int. J. Biochem. Cell. Biol.
Peptidergic nerves in the eye, their source and potential pathophysiological relevance
Brain Res. Rev.
Alarin stimulates food intake in male rats and LH secretion in castrated male rats
Neuropeptides
Molecular analysis of neurolysin expression in the rat and bovine ciliary body
Curr. Eye Res.
Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in the rat gastric fundus
J. Pharmacol. Exp. Ther.
Alarin stimulates food intake and gonadotrophin release in male rats
Br. J. Pharmacol.
Cited by (12)
Acute central effects of alarin on the regulation on energy homeostasis
2017, NeuropeptidesCitation Excerpt :Alarin, a 25 amino-acid peptide, is the newest member of the galanin peptide family found first in gangliocytes of human neuroblastic tumors (Santic et al., 2006). Alarin has also been shown to be localized around the blood vessels with vasoactive actions (Santic et al., 2007) and may have a role in ocular blood flow regulation (Schrödl et al., 2013). In addition, it increases the secretion of luteinizing hormone in male mice (Fraley et al., 2012), has antidepressant-like (Wang et al., 2014, 2015; Zhuang et al., 2016) and antimicrobial (Wada et al., 2013) effects.
Cytokines and glucocorticoid receptors are associated with the antidepressant-like effect of alarin
2016, PeptidesCitation Excerpt :Alarin is a recently discovered member of the galanin peptide family that is derived from a splice variant of galanin-like peptide, which excludes exon 3, first found in gangliocytes of human neuroblastic tumors [2]. Because of the lack of a galanin receptor binding domain [3–5], alarin is unable to bind galanin receptors to exert biological effects. Thus, few studies have examined the physiological roles, pharmacological properties, or underlying mechanisms of alarin.
Alarin in cranial autonomic ganglia of human and rat
2015, Experimental Eye ResearchCitation Excerpt :It is a splice variant of the galanin-like peptide (GALP) mRNA lacking exon3, missing the galanin-receptor binding domain and possibly using different receptors for its action. As it is detected around blood vessels (Santic et al., 2007; Schrodl et al., 2013) and shows vasoconstrictive activity in a murine inflammation model (Santic et al., 2007), a vasomodulatory activity in the eye seems plausible. Alarin is detected in intrinsic choroidal neurons (Schrodl et al., 2013) and also nerve fibers of the choroidal stroma (this study), the question of origin of this neuronal alarin is important (in this sense, the assignation into the class of neuropeptides seems justified): while alr-LI nerve fibers within the choroid could derive from intrinsic sources (intrinsic choroidal neurons), they could also originate from extrinsic sources (cranial autonomic ganglia).
Alarin-induced antidepressant-like effects and their relationship with hypothalamus-pituitary-adrenal axis activity and brain derived neurotrophic factor levels in mice
2014, PeptidesCitation Excerpt :It was shown that in the periphery, alarin has the anti-edema effect due to its function as a vasoconstrictor [47]. A recent study showed that alarin was detected in various ocular tissues and its involvement in ocular health was confirmed [50]. In CNS, intercerebroventricular (i.c.v.) injection of alarin dose-dependently increased acute food intake [3,58] and body weight.
The evolving roles of alarin in physiological and disease conditions, and its future potential clinical implications
2022, Frontiers in Endocrinology
- 1
Present address: LKH Leoben, Vordernberger Straβe 42, 8700 Leoben, Austria.
- 2
Present address: AFFiRiS AG, Vienna Biocenter, 1030 Vienna, Austria.
- 3
Authors contributed equally to this work.